Capivasertib | CAS 1143532-39-1 - Request Quote
Capivasertib
| SZ CAT No: | SZ-C254001 |
| CAS No | 1143532-39-1 |
| Mol.F. | C21H25ClN6O2 |
| Mol.Wt. | 428.9 |
| Inv. Status | In Stock |
| Rel. CAS No | 2108875-84-7 (2HCl salt) |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Capivasertib is chemically (S)-4-Amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide. Capivasertib is supplied with detailed characterization data compliant with regulatory guideline. Capivasertib can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Capivasertib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1143532-39-1
Purchase 1143532-39-1
Order 1143532-39-1
Enquire 1143532-39-1
price of 1143532-39-1
1143532-39-1 Supplier
1143532-39-1 Manufacturer
1143532-39-1 Exporter
buy high quality Capivasertib
Purchase Capivasertib
Capivasertib suppliers
Capivasertib manufacturers
Capivasertib price
Order Capivasertib
Enquire Capivasertib
Capivasertib cost
Capivasertib Supplier
Capivasertib Distributor
Capivasertib for Method Validation
Capivasertib Reference Standard
Capivasertib for ANDA Filing
Capivasertib for Forced Degradation Studies
Capivasertib Identification Standards
Capivasertib for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


